MetLife Allowance for loan losses increased by 1.7% to $1.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.6%, from $981.00M to $1.21B. Over 5 years (FY 2020 to FY 2025), Allowance for loan losses shows an upward trend with a 15.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to total receivables may signal deteriorating credit quality or a more conservative risk assessment.
This is a contra-asset account representing the estimated amount of financing receivables that the company does not expe...
Standard for any company with a lending or credit-based business model.
non_current_assets_financing_receivable_allowance_for_cr_f5b0a7| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $570.00M | $563.00M | $634.00M | $615.00M | $486.00M | $467.00M | $527.00M | $692.00M | $724.00M | $705.00M | $721.00M | $814.00M | $806.00M | $847.00M | $800.00M | $981.00M | $1.20B | $1.26B | $1.19B | $1.21B |
| QoQ Change | — | -1.2% | +12.6% | -3.0% | -21.0% | -3.9% | +12.8% | +31.3% | +4.6% | -2.6% | +2.3% | +12.9% | -1.0% | +5.1% | -5.5% | +22.6% | +21.9% | +5.4% | -5.4% | +1.7% |
| YoY Change | — | — | — | — | -14.7% | -17.1% | -16.9% | +12.5% | +49.0% | +51.0% | +36.8% | +17.6% | +11.3% | +20.1% | +11.0% | +20.5% | +48.4% | +48.9% | +49.1% | +23.6% |